Cargando…

Cohort profile: the STOP HIV/AIDS Program Evaluation (SHAPE) study in British Columbia, Canada

PURPOSE: The Seek and Treat for Optimal Prevention of HIV/AIDS (STOP HIV/AIDS) Program Evaluation (SHAPE) study is a longitudinal cohort developed to monitor the progress of an HIV testing and treatment expansion programme across the province of British Columbia (BC). The study considers how sociost...

Descripción completa

Detalles Bibliográficos
Autores principales: Bever, Andrea, Salters, Kate, Tam, Clara, Moore, D M, Sereda, Paul, Wang, Lu, Wesseling, Tim, Grieve, Sean, Bingham, Brittany, Barrios, Rolando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7228510/
https://www.ncbi.nlm.nih.gov/pubmed/32404387
http://dx.doi.org/10.1136/bmjopen-2019-033649
_version_ 1783534600898740224
author Bever, Andrea
Salters, Kate
Tam, Clara
Moore, D M
Sereda, Paul
Wang, Lu
Wesseling, Tim
Grieve, Sean
Bingham, Brittany
Barrios, Rolando
author_facet Bever, Andrea
Salters, Kate
Tam, Clara
Moore, D M
Sereda, Paul
Wang, Lu
Wesseling, Tim
Grieve, Sean
Bingham, Brittany
Barrios, Rolando
author_sort Bever, Andrea
collection PubMed
description PURPOSE: The Seek and Treat for Optimal Prevention of HIV/AIDS (STOP HIV/AIDS) Program Evaluation (SHAPE) study is a longitudinal cohort developed to monitor the progress of an HIV testing and treatment expansion programme across the province of British Columbia (BC). The study considers how sociostructural determinants such as gender, age, sexual identity, geography, income and ethnicity influence engagement in HIV care. PARTICIPANTS: Between January 2016 and September 2018, 644 BC residents who were at least 19 years old and diagnosed with HIV were enrolled in the study and completed a baseline survey. Participants will complete two additional follow-up surveys (18 months apart) about their HIV care experiences, with clinical follow-up ongoing. FINDINGS TO DATE: Analyses on baseline data have found high levels of HIV care engagement and treatment success among SHAPE participants, with 95% of participants receiving antiretroviral therapy and 90% having achieved viral suppression. However, persistent disparities in HIV treatment outcomes related to age, injection drug use and housing stability have been identified and require further attention when delivering services to marginalised groups. FUTURE PLANS: Our research will examine how engagement in HIV care evolves over time, continuing to identify barriers and facilitators for promoting equitable access to treatment and care among people living with HIV. A qualitative research project, currently in the formative phase, will compliment quantitative analyses by taking a strengths-based approach to exploring experiences of engagement and re-engagement in HIV treatment among individuals who have experienced delayed treatment initiation or treatment interruptions.
format Online
Article
Text
id pubmed-7228510
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-72285102020-05-18 Cohort profile: the STOP HIV/AIDS Program Evaluation (SHAPE) study in British Columbia, Canada Bever, Andrea Salters, Kate Tam, Clara Moore, D M Sereda, Paul Wang, Lu Wesseling, Tim Grieve, Sean Bingham, Brittany Barrios, Rolando BMJ Open Public Health PURPOSE: The Seek and Treat for Optimal Prevention of HIV/AIDS (STOP HIV/AIDS) Program Evaluation (SHAPE) study is a longitudinal cohort developed to monitor the progress of an HIV testing and treatment expansion programme across the province of British Columbia (BC). The study considers how sociostructural determinants such as gender, age, sexual identity, geography, income and ethnicity influence engagement in HIV care. PARTICIPANTS: Between January 2016 and September 2018, 644 BC residents who were at least 19 years old and diagnosed with HIV were enrolled in the study and completed a baseline survey. Participants will complete two additional follow-up surveys (18 months apart) about their HIV care experiences, with clinical follow-up ongoing. FINDINGS TO DATE: Analyses on baseline data have found high levels of HIV care engagement and treatment success among SHAPE participants, with 95% of participants receiving antiretroviral therapy and 90% having achieved viral suppression. However, persistent disparities in HIV treatment outcomes related to age, injection drug use and housing stability have been identified and require further attention when delivering services to marginalised groups. FUTURE PLANS: Our research will examine how engagement in HIV care evolves over time, continuing to identify barriers and facilitators for promoting equitable access to treatment and care among people living with HIV. A qualitative research project, currently in the formative phase, will compliment quantitative analyses by taking a strengths-based approach to exploring experiences of engagement and re-engagement in HIV treatment among individuals who have experienced delayed treatment initiation or treatment interruptions. BMJ Publishing Group 2020-05-12 /pmc/articles/PMC7228510/ /pubmed/32404387 http://dx.doi.org/10.1136/bmjopen-2019-033649 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Public Health
Bever, Andrea
Salters, Kate
Tam, Clara
Moore, D M
Sereda, Paul
Wang, Lu
Wesseling, Tim
Grieve, Sean
Bingham, Brittany
Barrios, Rolando
Cohort profile: the STOP HIV/AIDS Program Evaluation (SHAPE) study in British Columbia, Canada
title Cohort profile: the STOP HIV/AIDS Program Evaluation (SHAPE) study in British Columbia, Canada
title_full Cohort profile: the STOP HIV/AIDS Program Evaluation (SHAPE) study in British Columbia, Canada
title_fullStr Cohort profile: the STOP HIV/AIDS Program Evaluation (SHAPE) study in British Columbia, Canada
title_full_unstemmed Cohort profile: the STOP HIV/AIDS Program Evaluation (SHAPE) study in British Columbia, Canada
title_short Cohort profile: the STOP HIV/AIDS Program Evaluation (SHAPE) study in British Columbia, Canada
title_sort cohort profile: the stop hiv/aids program evaluation (shape) study in british columbia, canada
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7228510/
https://www.ncbi.nlm.nih.gov/pubmed/32404387
http://dx.doi.org/10.1136/bmjopen-2019-033649
work_keys_str_mv AT beverandrea cohortprofilethestophivaidsprogramevaluationshapestudyinbritishcolumbiacanada
AT salterskate cohortprofilethestophivaidsprogramevaluationshapestudyinbritishcolumbiacanada
AT tamclara cohortprofilethestophivaidsprogramevaluationshapestudyinbritishcolumbiacanada
AT mooredm cohortprofilethestophivaidsprogramevaluationshapestudyinbritishcolumbiacanada
AT seredapaul cohortprofilethestophivaidsprogramevaluationshapestudyinbritishcolumbiacanada
AT wanglu cohortprofilethestophivaidsprogramevaluationshapestudyinbritishcolumbiacanada
AT wesselingtim cohortprofilethestophivaidsprogramevaluationshapestudyinbritishcolumbiacanada
AT grievesean cohortprofilethestophivaidsprogramevaluationshapestudyinbritishcolumbiacanada
AT binghambrittany cohortprofilethestophivaidsprogramevaluationshapestudyinbritishcolumbiacanada
AT barriosrolando cohortprofilethestophivaidsprogramevaluationshapestudyinbritishcolumbiacanada